Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.

Xin L, Teitell MA, Lawson DA, Kwon A, Mellinghoff IK, Witte ON.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7789-94. Epub 2006 May 8.

2.
3.

Mechanisms of prostate cancer cell survival after inhibition of AR expression.

Cohen MB, Rokhlin OW.

J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. Review.

PMID:
19115258
5.

Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.

J Cell Biochem. 2006 Oct 1;99(2):392-401. Review.

PMID:
16639715
6.

Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.

Buchanan G, Ricciardelli C, Harris JM, Prescott J, Yu ZC, Jia L, Butler LM, Marshall VR, Scher HI, Gerald WL, Coetzee GA, Tilley WD.

Cancer Res. 2007 Oct 15;67(20):10087-96.

8.

Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.

Asim M, Siddiqui IA, Hafeez BB, Baniahmad A, Mukhtar H.

Oncogene. 2008 Jun 5;27(25):3596-604. doi: 10.1038/sj.onc.1211016. Epub 2008 Jan 28.

PMID:
18223692
9.

Androgen signaling and its interactions with other signaling pathways in prostate cancer.

Kaarbø M, Klokk TI, Saatcioglu F.

Bioessays. 2007 Dec;29(12):1227-38. Review.

PMID:
18008377
10.

Androgen receptor and invasion in prostate cancer.

Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE.

Cancer Res. 2008 Feb 15;68(4):1128-35. doi: 10.1158/0008-5472.CAN-07-1929.

11.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
13.

Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway.

Sun HZ, Yang TW, Zang WJ, Wu SF.

J Endocrinol. 2010 Mar;204(3):311-8. doi: 10.1677/JOE-09-0270. Epub 2009 Dec 10.

14.

Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.

Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ.

Cancer Res. 2006 Nov 15;66(22):11047-54.

15.

Androgen receptor cross-talk with cell signalling pathways.

Culig Z.

Growth Factors. 2004 Sep;22(3):179-84. Review.

PMID:
15518241
16.

Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains.

Cinar B, Mukhopadhyay NK, Meng G, Freeman MR.

J Biol Chem. 2007 Oct 5;282(40):29584-93. Epub 2007 Jul 16.

17.

Beta-catenin signaling in prostate cancer: an early perspective.

Chesire DR, Isaacs WB.

Endocr Relat Cancer. 2003 Dec;10(4):537-60. Review.

18.

Conditional Akt activation promotes androgen-independent progression of prostate cancer.

Li B, Sun A, Youn H, Hong Y, Terranova PF, Thrasher JB, Xu P, Spencer D.

Carcinogenesis. 2007 Mar;28(3):572-83. Epub 2006 Oct 10.

PMID:
17032658
19.

Androgen receptor regulates CD168 expression and signaling in prostate cancer.

Lin SL, Chang D, Chiang A, Ying SY.

Carcinogenesis. 2008 Feb;29(2):282-90. doi: 10.1093/carcin/bgm259. Epub 2008 Jan 3.

PMID:
18174258
20.

Supplemental Content

Support Center